Transforming growth factor-beta 1 reduces infarct size after experimental cerebral ischemia in a rabbit model.
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The aim of this study was to examine the effect of transforming growth factor-beta 1, a cytokine shown to amelioriate cardiac ischemia, in a rabbit model of thromboembolic stroke. An autologous clot embolus was introduced intracranially through the right internal carotid artery in 21 New Zealand White rabbits, with seven in each group receiving either vehicle control (albumin) or 10 or 50 micrograms transforming growth factor-beta 1 administered as an intracarotid bolus immediately before autologous clot embolization. Multiple physiological parameters were monitored, including regional cerebral blood flow, arterial blood gases, hematocrit, glucose, core temperature, and mean arterial pressure. The brain was harvested 4 hours after embolization, and infarct size was determined planimetrically as a percentage of the entire hemisphere. Brain infarct size was reduced in both the 10-microgram (16.7 +/- 4.0% [mean +/- SEM], p < 0.05) and 50-microgram (21.7 +/- 4.5%) transforming growth factor-beta 1-treated groups when compared with the control group (31.9 +/- 6.6%). Regional cerebral blood flow did not show any significant intergroup or intragroup variation over time, although the 10-microgram transforming growth factor-beta 1 group experienced a greater return of cerebral blood flow in the first 2 hours after embolization. Transforming growth factor-beta 1 reduced brain infarct size in a rabbit model of thromboembolic stroke. This effect was not related to a direct effect on blood flow. Studies are ongoing to determine the mechanism by which transforming growth factor-beta 1 salvages ischemic brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta.
Postlethwaite, A. E., Keski-Oja, J., Moses, H. L., & Kang, A. H. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.1.251 · Cited by 777
Mattson, M., Murrain, M., Guthrie, P., & Kater, S. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-11-03728.1989 · Cited by 480
Regulation of Cell Adhesion Receptors by Transforming Growth Factor-β
Ignotz, R. A., Heino, J., & Massagué, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31270-x · Cited by 269
Cited by
Inflammation and glial responses in ischemic brain lesions
Stoll, G. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00034-3 · Cited by 795
Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs
Reiber, H., & Peter, J. B. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00501-3 · Cited by 731
Cheng, B., Christakos, S., & Mattson, M. P. (1994) · Neuron · doi:10.1016/0896-6273(94)90159-7 · Cited by 668
Inflammation in stroke and focal cerebral ischemia
Huang, J., Upadhyay, U. M., & Tamargo, R. J. (2006) · Surgical Neurology · doi:10.1016/j.surneu.2005.12.028 · Cited by 649
Maida, C. D., Norrito, R. L., Daidone, M., Tuttolomondo, A., & Pinto, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186454 · Cited by 589
Dynamics of brain-derived proteins in cerebrospinal fluid
Reiber, H. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00573-3 · Cited by 516
Common pathological processes in Alzheimer disease and type 2 diabetes: A review
Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367
TRANSFORMING GROWTH FACTOR-βS IN NEURODEGENERATIVE DISEASE
FLANDERS, K. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00066-x · Cited by 364
MATTSON, M. P., & SCHEFF, S. W. (1994) · Journal of Neurotrauma · doi:10.1089/neu.1994.11.3 · Cited by 309
Astrocytes in cerebral ischemic injury: Morphological and general considerations
Panickar, K. S., & Norenberg, M. D. (2005) · Glia · doi:10.1002/glia.20181 · Cited by 297
Guido, S., Sebastian, J., & Schroeter, M. (2003) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0123-7_3 · Cited by 276
Reperfusion Injury after Focal Cerebral Ischemia: The Role Inflammation and the The rapeutic Horizon
Jean, W. C., Spellman, S. R., Nussbaum, E. S., & Low, W. C. (1998) · Neurosurgery · doi:10.1097/00006123-199812000-00076 · Cited by 264
Cytokines and adhesion molecules in stroke and related diseases
Kim, J. S. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00338-3 · Cited by 216
Henrich-Noack, P., Prehn, J. H. M., & Krieglstein, J. (1996) · Stroke · doi:10.1161/01.str.27.9.1609 · Cited by 202
TGF‐β1 is an organizer of responses to neurodgeneration
Finch, C. E., Laping, N. J., Morgan, T. E., Nichols, N. R., & Pasinetti, G. M. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240530408 · Cited by 165
Buckwalter, M. S., Yamane, M., Coleman, B. S., Ormerod, B. K., Chin, J. T., Palmer, T., & Wyss-Coray, T. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051272 · Cited by 127
An Overview of Acute Stroke Therapy: Past, Present, and Future
Fisher, M., & Schaebitz, W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3196 · Cited by 112
TGF-β Pathway as a Potential Target in Neurodegeneration and Alzheimers
Wyss-Coray, T. (2006) · Current Alzheimer Research · doi:10.2174/156720506777632916 · Cited by 85
Wang, Y., Moges, H., Bharucha, Y., & Symes, A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.006 · Cited by 84
Metadata
- Authors
- Gross, C. E., Bednar, M. M., Howard, D. B., & Sporn, M. B.
- Venue
- Stroke
- Published
- 1993-04
- Volume
- 24
- Issue
- 4
- Pages
- 558-562
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2032968014
- Cited by
- 153
- References
- 3
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.